Different roles of N- and C- termini in the functional activity of FGF21 (Q24312210)

fibroblast growth factor binding

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author name string

Radmila Micanovic

1

0 references

David W Raches

2

0 references

James D Dunbar

3

0 references

David A Driver

4

0 references

Holly A Bina

5

0 references

Craig D Dickinson

6

0 references

Alexei Kharitonenkov

Journal of Cellular Physiology

7

0 references

language of work or name

English

0 references

publication date

May 2009

0 references

published in

0 references

volume

219

0 references

issue

2

0 references

page(s)

227-34

0 references

cites work

The Klotho gene family and the endocrine fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Cellular signaling by fibroblast growth factor receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

FGF23 and disorders of phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Fibroblast growth factor signaling in tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Structural basis for fibroblast growth factor receptor activation

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

The crystal structure of fibroblast growth factor (FGF) 19 reveals novel features of the FGF family and offers a structural basis for its unusual receptor affinity

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Klotho converts canonical FGF receptor into a specific receptor for FGF23

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

BetaKlotho is required for metabolic activity of fibroblast growth factor 21

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

FGF-21 as a novel metabolic regulator

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Fibroblast growth factor 21 corrects obesity in mice

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

1 reference

https://api.crossref.org/works/10.1002%2FJCP.21675

7 January 2021